Therapeutics company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Diametica Therapeutics in the last 30 days yet.
The 1 sources with the most insights about Diametica Therapeutics on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
A 10% owner with a previously successful track record purchased over $11 million worth of stock, suggesting a high level of confidence in the company's future.
A 10% owner with a previously successful track record purchased over $11 million worth of stock, suggesting a high level of confidence in the company's future.
Other assets that creators frequently mention in the same content as Diametica Therapeutics.
The most active sources covering Diametica Therapeutics (DMTC) on Kazuha are @ceowatcher. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Diametica Therapeutics (DMTC) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Diametica Therapeutics (DMTC) most frequently also discuss ORI, PARR, TPVG, ULCC, DK. See the "Discussed alongside" section above for full asset pages.